Event
DIA CoRE Singapore Annual Meeting 2022
calendar

July 12 - 13, 2022

Calendar
clock

8:30am - 5:30pm

(GMT+08:00)

map point

Grand Copthorne Waterfront Hotel, Singapore

Singapore

View map
Register

View all IQVIA events

In its 5th anniversary, DIA CoRE Singapore Annual Meeting is returning to face-to-face format with the overall theme of ‘Aspirations for the Future of Healthcare – From Ideas to Actions’. This year, an open dialogue will be conducted where healthcare experts share their insights on:

  • Current Asia Pacific and global regulatory landscape;
  • Emerging technology and methodologies in drug development;
  • Policy, regulatory and infrastructure considerations
  • Digital health in Asia Pacific;
  • Approaches in Balancing Science and Operations for Better Access;
  • Adoption of DCTs, the challenges faced and what the future holds for DCT in Asia Pacific region;
  • Regulatory convergence, reliance and alternative pathways;

COVID-19 has ushered in a new wave of healthcare innovations. From technological adoption to regulatory updates in drug development, learn how to remain responsive to a changing healthcare landscape, translate ideas into tangible actions and grow in a sustainable manner. Register for the meeting here.

At DIA #SAM2022, join our IQVIA expert speakers at the following sessions:

Session 1 - Fostering Digital Health Adoption in the Asia-Pacific

Realise the full potential of digital health in APAC. IQVIA expert, Sherry Wang, Principal and Head of Commercial Regulatory Services, and other distinguished speakers will share on the different aspects of digital health, degree of regional adoption and application as well as clarifications regarding the regulatory frameworks.

Session 2 – The Dynamics of Decentralised Clinical Trials

Due to the COVID-19 pandemic, adoption of decentralized clinical trials (DCT) has become even more widespread. IQVIA expert Jerome Armellini, Head of Clinical Development & Operations Strategy, R&D Solutions Asia, will share his perspectives on the safe adoption of DCT, challenges faced and the future of DCT in the APAC region to achieve a patient centric and sustainable approach.

Session 3 – Balancing Science and Operations for Better Access to Cell and Gene Therapy (CAGT)

Cell and gene therapy (CAGT) represents the pinnacle of innovations in managing cancer. Practitioners face many challenges inclusive of logistical frameworks and clinical development regulations. Senthil Sockalingam, Head of IQVIA Biotech JAPAC and Chief Medical Officer – APAC, will engage in discussion on the direction of CAGT drug development and how to navigate the complexity of associated regulatory frameworks.

Click here to register for the DIA CoRE Singapore Annual Meeting 2022.

Contact Us